combivent respimat- ipratropium bromide and albuterol spray, metered
boehringer ingelheim pharmaceuticals inc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 20 ug - combivent respimat is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta2 -adrenergic agonist) indicated for use in patients with chronic obstructive pulmonary disease (copd) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator. combivent respimat is contraindicated in the following conditions [see warnings and precautions (5.6) ]: - hypersensitivity to any of the ingredients in combivent respimat - hypersensitivity to atropine or any of its derivatives risk summary there are no randomized clinical studies of combivent respimat, or its individual components, ipratropium bromide and albuterol sulfate, in pregnant women. ipratropium is negligibly absorbed systemically following oral inhalation; therefore, maternal use is not expected to result in fetal exposure to the drug [see clinical pharmacology (12.3)] . published literature, including cohort studies, case control studies and case series, over s
combivent
boehringer ingelheim (nz) limited - ipratropium bromide monohydrate 21ug; salbutamol sulfate 120ug - aerosol inhaler, metered dose - 120µg/21µg per dose - active: ipratropium bromide monohydrate 21ug salbutamol sulfate 120ug excipient: dichlorodifluoromethane lecithin trichlorofluoromethane
combivent udvs 0.5/2.5 mg/mg nebuliser solution
boehringer ingelheim limited - ipratropium bromide monohydrate, salbutamol sulfate - nebuliser solution - 0.5/2.5 mg/mg - adrenergics in combination with anticholinergics
combivent nebuliser liquid 2.5ml udvs
boehringer ingelheim ltd - ipratropium bromide; salbutamol sulfate - nebuliser liquid - 200microgram/1ml ; 1mg/1ml
combivent udv solution
boehringer ingelheim (canada) ltd ltee - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide (ipratropium bromide monohydrate) 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics
combivent unit dose vial for inhalation
boehringer ingelheim singapore pte. ltd. - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol - solution - 0.5 mg/2.5 ml - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous 0.5 mg/2.5 ml; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol 2.500 mg/2.5 ml
combivent respimat solution
boehringer ingelheim (canada) ltd ltee - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 20mcg; 100mcg - ipratropium bromide (ipratropium bromide monohydrate) 20mcg; salbutamol (salbutamol sulfate) 100mcg - antimuscarinics antispasmodics
combivent metered aersol
imbat limited - ipratropium bromide/salbutamol - unknown - 20/100 mcg/acutuation
combivent metered aersol 20/100 mcg/acutuation unknown
imbat limited - ipratropium bromide/salbutamol - unknown - 20/100 mcg/acutuation
combivent nebuliser solution in unit dose vial
boehringer ingelheim (malaysia) sdn. bhd. - salbutamol sulphate; ipratropium bromide monohydrate -